29th Apr 2016 17:43
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibilities or Connected Persons
The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the 'Plan') notified GlaxoSmithKline plc ('GSK') on 28 April 2016 that the under-mentioned Directors, Persons Discharging Managerial Responsibilities ('PDMR') and Connected Persons acquired notional Ordinary Shares at a price of 1502.00 pence per Ordinary Share and American Depositary Shares ('ADSs') at a price of $42.64 per ADS, following the notional re-investment of the dividend paid to shareholders on 14 April 2016.
Director/PDMR | Ordinary Shares | ADSs |
Sir Andrew Witty | 41,688.082 | |
Dr M M Slaoui | 12,095.870 | |
Mr S Dingemans | 17,503.320 | |
Mr R G Connor | 8,568.501 | |
Mr N Hirons | 2,666.231 | 215.628 |
Mr S A Hussain | 17,903.405 | |
Mr D S Redfern | 6,379.260 | |
Ms C Thomas | 8,495.290 | |
Mr P C Thomson | 4,638.016 | |
Mr D E Troy | 7,534.332 | |
Dr P J T Vallance | 18,629.480 | |
Ms E Walmsley | 14,203.165 | |
Mrs V A Whyte | 1,072.219 |
Connected Person |
Ordinary Shares |
ADSs |
Dr K Slaoui (Connected Person to Dr M M Slaoui) | 184.627 |
The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).
V A Whyte
Company Secretary
29 April 2016
Related Shares:
Glaxosmithkline